* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Hepalink Pharmaceutical Group Co Days Payable Chart
Shenzhen Hepalink Pharmaceutical Group Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Hepalink Pharmaceutical Group Co Days Payable vs Drug Manufacturers Industry
Shenzhen Hepalink Pharmaceutical Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) has a Days Payable of 28.13 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shenzhen Hepalink Pharmaceutical Group Co and its competitors. This is near median its historical median of 26.77. Over the past decade, Shenzhen Hepalink Pharmaceutical Group Co's Days Payable has ranged from 20.38 to 36.53. According to the industry distribution chart, Shenzhen Hepalink Pharmaceutical Group Co ranks #807 out of 921 companies in the Drug Manufacturers industry, placing it in the top 87.6%.
Is Shenzhen Hepalink Pharmaceutical Group Co's Days Payable too high?
Shenzhen Hepalink Pharmaceutical Group Co's current Days Payable of 28.13 is near median its 10-year median of 26.77. Over the past 10 years, this metric has ranged from a low of 20.38 to a high of 36.53. The Drug Manufacturers industry median Days Payable is 90.69. Shenzhen Hepalink Pharmaceutical Group Co's value of 28.13 is 69% below this industry median. Based on the distribution chart, Shenzhen Hepalink Pharmaceutical Group Co ranks #807 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Hepalink Pharmaceutical Group Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Hepalink Pharmaceutical Group Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shenzhen Hepalink Pharmaceutical Group Co ranks #807 out of 921 companies for Days Payable. This places Shenzhen Hepalink Pharmaceutical Group Co in the lower half of its industry. The industry median Days Payable is 90.69. Shenzhen Hepalink Pharmaceutical Group Co's value of 28.13 is 69% below this benchmark. Historically, Shenzhen Hepalink Pharmaceutical Group Co's own Days Payable has ranged from 20.38 to 36.53 over the past decade. While the company's 10-year median is 26.77 vs. the industry median of 90.69, Shenzhen Hepalink Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Hepalink Pharmaceutical Group Co's current Days Payable of 28.13 is 69% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shenzhen Hepalink Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Hepalink Pharmaceutical Group Co's current Days Payable is 28.13, which is near median its own 10-year median of 26.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Hepalink Pharmaceutical Group Co stock overvalued right now?
Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) has a current Days Payable of 28.13. The stock's GF Value™ is $0.61, compared to a current price of $0.47 — trading 23% below its estimated fair value. The current Days Payable is 28.13, which is near median its 10-year median of 26.77 and 69% below the Drug Manufacturers industry median of 90.69. Shenzhen Hepalink Pharmaceutical Group Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shenzhen Hepalink Pharmaceutical Group Co (SHEZF), the current Days Payable is 28.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Hepalink Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of $0.47 is trading 23% below its estimated GF Value™ of $0.61.
Key valuation signals for SHEZF:
Days Payable: 28.13 (near median its 10-year median of 26.77)
GF Value™: $0.61 vs. price of $0.47 (23% below fair value)
Industry Position: 69% below the Drug Manufacturers median (#807 of 921)
No single metric tells the full story. See the SHEZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Hepalink Pharmaceutical Group Co Business Description
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company. Along with its subsidiary, it is engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development in Asia, Europe, North America, and Australia, and investment business in Asia and North America. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products; Active pharmaceutical ingredients; CDMO business; and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from Europe and the USA.
70GF Score
Get the complete analysis for SHEZF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHEZF has been successfully added to your 
